daunorubicin has been researched along with Chylopericardium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Hu, Y; Li, XD; Lin, DJ; Wang, DN; Wang, WW; Xiao, RZ | 1 |
| Mosher, D; Stein, JH; Vidarsson, B; Woods, T | 1 |
| Andersen, JW; Appelbaum, FR; Feusner, JH; François, C; Larson, RS; Ogden, A; Rowe, JM; Schiffer, CA; Shepherd, L; Tallman, MS; Wiernik, PH | 1 |
1 trial(s) available for daunorubicin and Chylopericardium
| Article | Year |
|---|---|
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Female; Fever; Glucocorticoids; Humans; Incidence; Infant; Leukemia, Promyelocytic, Acute; Lung; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Remission Induction; Respiratory Distress Syndrome; Syndrome; Tretinoin; Weight Gain | 2000 |
2 other study(ies) available for daunorubicin and Chylopericardium
| Article | Year |
|---|---|
Acute pleural and pericardial effusion induced by chemotherapy in treating chronic myelocytic leukemia.
Topics: Adult; Antineoplastic Agents; Cytarabine; Daunorubicin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pericardial Effusion; Pleural Effusion | 2014 |
Transient effusive-constrictive pericarditis due to chemotherapy.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Echocardiography; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pericardial Effusion; Pericarditis, Constrictive; Tomography, X-Ray Computed | 1999 |